Trial Profile
Treatment Sequences, Patient Characteristics and Overall Survival (OS) in Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 May 2018
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Abiraterone; Docetaxel; Enzalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 29 May 2018 New trial record